tiprankstipranks
Glaukos (GKOS)
NYSE:GKOS
US Market
GKOS
Glaukos
RESEARCH TOOLSreports

Glaukos (GKOS) Stock News & Sentiment

414 Followers
Glaukos Highlights Interventional Ophthalmology Strategy in Investor Update
Premium
Company Announcements
Glaukos Highlights Interventional Ophthalmology Strategy in Investor Update
1M ago
8K
GKOS
Glaukos Expands Eye Care Pipeline With New GLK-321 Trial in Demodex Blepharitis
Premium
Company Announcements
Glaukos Expands Eye Care Pipeline With New GLK-321 Trial in Demodex Blepharitis
1M ago
GKOS
Glaukos Refines Glaucoma Implant Delivery With New Inserter Study
Premium
Company Announcements
Glaukos Refines Glaucoma Implant Delivery With New Inserter Study
1M ago
GKOS
AI Adoption Raises Operational, Regulatory, and Reputational Risks for Glaukos Corp.
Premium
Company Announcements
AI Adoption Raises Operational, Regulatory, and Reputational Risks for Glaukos Corp.
1M ago
GKOS
Glaukos Corp. Earnings Call Signals High-Growth Phase
Premium
Company Announcements
Glaukos Corp. Earnings Call Signals High-Growth Phase
2M ago
GKOS
Glaukos (GKOS): Strong Execution, Expanding iDose Adoption, and De‑Risked Pipeline Support Buy Rating and $131 Target
Premium
Ratings
Glaukos (GKOS): Strong Execution, Expanding iDose Adoption, and De‑Risked Pipeline Support Buy Rating and $131 Target
2M ago
GKOS
Glaukos: Strengthening Growth, Epioxa Momentum, and Justified Premium Valuation Support Buy Rating
Premium
Ratings
Glaukos: Strengthening Growth, Epioxa Momentum, and Justified Premium Valuation Support Buy Rating
2M ago
GKOS
More GKOS News >

GKOS News on the Web

Glaukos price target raised to $135 from $125 at Citi
TipRanks News
Bullish
Seaport Research med technology analyst holds analyst/industry conference call
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Pelthos Therapeutics (PTHS), Aveanna Healthcare Holdings (AVAH) and Glaukos (GKOS)
TipRanks News
Bullish
Glaukos Launches Epioxa, Boosts Growth in Corneal Treatments
Zacks
Bullish
Stifel Nicolaus Sticks to Its Buy Rating for Glaukos (GKOS)
TipRanks News
Neutral
Glaukos Launches Epioxa: First FDA-Approved Incision-Free Topical Therapy for Keratoconus is Now Commercially Available
Market Chameleon
Neutral
Why Is Glaukos (GKOS) Down 14.7% Since Last Earnings Report?
Zacks
Bearish
Glaukos announces commercial availability of Epioxa HD/Epioxa
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
GKOS
Sector Average
Media Buzz
This Week1 articles
Weekly Average2.5 articles
News Sentiment
This Week100%
Sector Average67%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GKOS’s Media Buzz Sentiment?
1 articles about GKOS were published this week. In an average week, 2.5 articles are published.
    What is GKOS’s weekly average amount of articles?
    In an average week, 2.5 articles about GKOS are published.
      What is GKOS’s News Sentiment?
      100% of articles about GKOS were positive this week, compared to its sector average of 67%.
        Healthcare Stocks that are Trending in the News
        VCELVericel
        NBIXNeurocrine
        ANGOAngioDynamics
        ORGOOrganogenesis Holdings
        AORTArtivion
        Showing the stocks with the most bullish news sentiment over the past week